- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- 16
- 17
- 18
- 19
- 20
- 21
- 22
- 23
- 24
- 25
- 26
- 27
- 28
- 29
- 30
- 31
- 32
- 33
- 34
- 35
- 36
- 37
- 38
- 39
- 40
VRIO Analysis of Merck Schering-Plough Merger B
Posted by Zachary Edwards on Mar-22-2018
The VRIO Analysis of Merck Schering-Plough Merger B will look at each of its internal resources one by one to assess whether these provide sustained competitive advantage. The Merck Schering-Plough Merger B VRIO Analysis also mentions at each stage whether these resources could be improved to provide a greater competitive advantage. Lastly, the resources analysed are summarised as to whether they offer sustained competitive advantage, has an unused competitive advantage, temporary competitive advantage, competitive parity or competitive disadvantage.
Valuable
- The Merck Schering-Plough Merger B VRIO Analysis shows that the financial resources of Merck Schering-Plough Merger B are highly valuable as these help in investing into external opportunities that arise. These also help Merck Schering-Plough Merger B in combating external threats.
- According to the VRIO Analysis of Merck Schering-Plough Merger B, its local food products are a valuable resource as these are highly differentiated. This makes the perceived value for these by customers high. These are also valued more than the competition by customers due to the differentiation in these products.
- The Merck Schering-Plough Merger B VRIO Analysis shows that Merck Schering-Plough Merger B's employees are a valuable resource to the firm. A significant portion of the workforce is highly trained, and this leads to more productive output for the organisation. The employees are also loyal, and retention levels for the organisation are high. All of this translates into greater value for the end consumers of Merck Schering-Plough Merger B's products.
- According to the VRIO Analysis of Merck Schering-Plough Merger B, its patents are a valuable resource as these allow the firm to sell its products without competitive interference. This results in greater revenue for Merck Schering-Plough Merger B. These patents also provide Merck Schering-Plough Merger B with licensing revenue when it licenses these patents out to other manufacturers.
- The Merck Schering-Plough Merger B VRIO Analysis shows that Merck Schering-Plough Merger B’s distribution network is a valuable resource. This helps it in reaching out to more and more customers. This ensures greater revenues for Merck Schering-Plough Merger B. It also ensures that promotion activities translate into sales as the products are easily available.
- According to the VRIO Analysis of Merck Schering-Plough Merger B, its cost structure is not a valuable resource. This is because the methods of production lead to greater costs than that of competition, which affects the overall profits of the firm. Therefore, its cost structure is a competitive disadvantage that needs to be worked on.
- The Merck Schering-Plough Merger B VRIO Analysis shows that the research and development at Merck Schering-Plough Merger B is not a valuable resource. This is because research and development are costing more than the benefits it provides in the form of innovation. There have been very few innovative features and breakthrough products in the past few years. Therefore, research and development are a competitive disadvantage for Merck Schering-Plough Merger B. It is recommended that the research and development teams are improved, and costs are cut for these.
Rare
- The financial resources of Merck Schering-Plough Merger B are found to be rare according to the VRIO Analysis of Merck Schering-Plough Merger B. Strong financial resources are only possessed by a few companies in the industry.
- The local food products are found to be not rare as identified by Merck Schering-Plough Merger B VRIO Analysis. These are easily provided in the market by other competitors. This means that competitors can use these resources in the same way as Merck Schering-Plough Merger B and inhibit competitive advantage. This means that the local food products result in competitive parity for Merck Schering-Plough Merger B. As this resource is valuable, Merck Schering-Plough Merger B can still make use of this resource.
- The employees of Merck Schering-Plough Merger B are a rare resource as identified by the VRIO Analysis of Merck Schering-Plough Merger B. These employees are highly trained and skilled, which is not the case with employees in other firms. The better compensation and work environment ensure that these employees do not leave for other firms.
- The patents of Merck Schering-Plough Merger B are a rare resource as identified by the Merck Schering-Plough Merger B VRIO Analysis. These patents are not easily available and are not possessed by competitors. This allows Merck Schering-Plough Merger B to use them without interference from the competition.
- The distribution network of Merck Schering-Plough Merger B is a rare resource as identified by the VRIO Analysis of Merck Schering-Plough Merger B. This is because competitors would require a lot of investment and time to come up with a better distribution network than that of Merck Schering-Plough Merger B. These are also possessed by very few firms in the industry.
Imitable
- The financial resources of Merck Schering-Plough Merger B are costly to imitate as identified by the Merck Schering-Plough Merger B VRIO Analysis. These resources have been acquired by the company through prolonged profits over the years. New entrants and competitors would require similar profits for a long period of time to accumulate these amounts of financial resources.
- The local food products are not that costly to imitate as identified by the VRIO Analysis of Merck Schering-Plough Merger B. These can be acquired by competitors as well if they invest a significant amount in research and development. These also do not require years long experience. Therefore, the local food products by Merck Schering-Plough Merger B provide it with a temporary competitive advantage that competitors can too acquire in the long run.
- The employees of Merck Schering-Plough Merger B are also not costly to imitate as identified by the Merck Schering-Plough Merger B VRIO Analysis. This is because other firms can also train their employees to improve their skills. These companies can also hire employees from Merck Schering-Plough Merger B by offering better compensation packages, work environment, benefits, growth opportunities etc. This makes the employees of Merck Schering-Plough Merger B a resource that provides a temporary competitive advantage. Competition can acquire these in the future.
- The patents of Merck Schering-Plough Merger B are very difficult to imitate as identified by the VRIO Analysis of Merck Schering-Plough Merger B. This is because it is not legally allowed to imitate a patented product. Similar resources to be developed and getting a patent for them is also a costly process.
- The distribution network of Merck Schering-Plough Merger B is also very costly to imitate by competition as identified by the Merck Schering-Plough Merger B VRIO Analysis. This has been developed over the years gradually by Merck Schering-Plough Merger B. Competitors would have to invest a significant amount if they are to imitate a similar distribution system.
Organisation
- The financial resources of Merck Schering-Plough Merger B are organised to capture value as identified by the VRIO Analysis of Merck Schering-Plough Merger B. These resources are used strategically to invest in the right places; making use of opportunities and combatting threats. Therefore, these resources prove to be a source of sustained competitive advantage for Merck Schering-Plough Merger B.
- The Patents of Merck Schering-Plough Merger B are not well organised as identified by the Merck Schering-Plough Merger B VRIO Analysis. This means that the organisation is not using these patents to their full potential. An unused competitive advantage exists that can be changed into a sustainable competitive advantage if Merck Schering-Plough Merger B starts selling patented products before the patents expire.
- The distribution network of Merck Schering-Plough Merger B is organised as identified by the VRIO Analysis of Merck Schering-Plough Merger B. Merck Schering-Plough Merger B uses this network to reach out to its customers by ensuring that products are available on all of its outlets. Therefore, these resources prove to be a source of sustained competitive advantage for Merck Schering-Plough Merger B.
From the VRIO Analysis of Merck Schering-Plough Merger B, it was identified that the financial resources and distribution network provide a sustained competitive advantage. The patents are a source of unused competitive advantage. There exists a temporary competitive advantage for employees. There exists a competitive parity for local food products. Lastly, the cost structure of Merck Schering-Plough Merger B is a competitive disadvantage. Research and Development is also a competitive disadvantage.
Warning! This article is only an example and cannot be used for research or reference purposes. If you need help with something similar, please submit your details here.
Daniel Bay
5.0
Everyone that belongs to this service is very active and always replies on time. Thanks for supplying me with the paper that met all my requirements!
Bob Philip
5.0
I have just referred your service to my friend and hope he would like it. Please compose his paper in the same way as you write to mine.
Florence Nathan
5.0
Would like to suggest this service to those who have problems for catching their papers up. I'm suggesting this service because I belong to the category of those students who visited this service on the recommendation.
Mia Benjamin
5.0
The expert finished the assignment with the necessary data. There was not even one sentence that was wordy. Very pleased to be the part of this service.
Next Articles
- ImmuLogic Pharmaceutical Corp. (B1): Malcolm Gefter Vrio Analysis
- Procurement At Betapharm Corp. (C) Vrio Analysis
- ALZA And Bio Electro Systems (C): 1988 92 Vrio Analysis
- ImmuLogic Pharmaceutical Corp. (C): April 1991 Vrio Analysis
- Boston Physicians Devices Vrio Analysis
- Chadwick, Inc.: The Balanced Scorecard, Spanish Version Vrio Analysis
- Merck: Managing Vioxx (B) Vrio Analysis
- Pharmacyclics: Financing Research & Development Vrio Analysis
- Kendle International, Inc. Vrio Analysis
- Bio Tech, Inc. Vrio Analysis
Previous Articles
- Richardson Vicks 1985 (B) Vrio Analysis
- Richardson Vicks 1985 (A) Vrio Analysis
- RadNet, Inc.: Financing An Acquisition Vrio Analysis
- Pfizer: Letter From The Chairman (A) Vrio Analysis
- Biosensors International Group: Valuation And Impairment Testing Of Intangibles Vrio Analysis
- Pfizer: Letter From The Chairman (B) Vrio Analysis
- Standard International, Inc. (B) Vrio Analysis
- BreatheScreen Inc. Transaction Analysis And Financial Statements Vrio Analysis
- Merck: Managing Vioxx (C), Spanish Version Vrio Analysis
- Home Nursing Of North Carolina Vrio Analysis
Be a great writer or hire a greater one!
Academic writing has no room for errors and mistakes. If you have BIG dreams to score BIG, think out of the box and hire Case48 with BIG enough reputation.
Our Guarantees
Interesting Fact
Most recent surveys suggest that around 76 % students try professional academic writing services at least once in their lifetime!